Registry of Subject Treated With ClariFix (SNIF)

Arrinex

Status: Completed

Conditions: Chronic Rhinitis

Treatments: Device: ClariFix

Study type: Observational

Funder types: Industry

Identifiers

NCT03739216

CT-0004

Details and patient eligibility

About

A multi-center, prospective, non-randomized, observational registry to asses the results of the ClariFix(TM) device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis.

Enrollment: 354 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participant is scheduled to receive treatment with the ClariFix device in accordance with the ClariFix Instructions for Use.
• Participant is able to provide consent and willing to adhere to the study visit schedule.

Exclusion criteria

• Participant is scheduled to have additional treatment and/or procedures completed at the same time of treatment with the ClariFix device.
• Participant is scheduled to have additional nasal or sinus treatments and/or procedures completed within 3 months of treatment with the ClariFix device.

Trial design

354 participants in 1 patient group

Open label

Description:

Open label registry study of patients treated with the ClariFix device for chronic rhinitis.

Treatment:

Device: ClariFix